The study, published Monday in the journal Nature Medicine, is one of the first big-picture looks at the benefits and risks of these new drugs, which rapidly made an impact on health care, insurance coverage, the grocery industry, and even the economy of an entire country (Denmark, where Novo Nordisk, the maker of Ozempic and Wegovy is based.) These drugs have also been given partial credit for a recent dip in obesity rates in the US, which dropped in 2023 for the first time in over a decade
Can I Drink Alcohol While On GLP-1
Key takeaways The drugs act on the same receptor, but differences in pharmacokinetics and potency alter dosing, effectiveness, and the pattern of side effects
The initial phase is all about subtle, internal shifts that create a cascade of metabolic effects down the line